Stay updated with breaking news from Identifying Hypercortisolism. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The panel concludes by discussing the long-term outcomes for patients treated for hypercortisolism, emphasizing the need for further studies and data, and sharing their final thoughts on the disease and its future management.
Medical professionals discuss their ideal patients for surgery, and who would be best suited for pharmacologic intervention.
Panelists emphasize the importance of addressing underlying hypercortisolism, as it can lead to the development of osteoporosis and cardiovascular complications.
Panelists review current guidelines for treating hypercortisolism, noting the need for guidelines to align with recent advancements, and share their own clinical practice approaches.
Christopher Lucci, MD, reviews the current diagnostic tests for hypercortisolism, which include the Dexamethasone Suppression Test, DHEA level tests, and ACTH assessments.